
|Videos|September 7, 2021
CLL: Final Thoughts
An expert panel provides their final thoughts about the future of the chronic lymphocytic leukemia (CLL) treatment landscape.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on OncLive
1
Patient-Level Data Show Extended OS Advantage With DCVax-L vs External Controls in Glioblastoma
2
Zoldonrasib Combinations Show Compelling Antitumor Activity in RAS G12D–Mutant Metastatic PDAC
3
FDA Approves Subcutaneous Isatuximab Delivered Via On-Body Delivery System for Multiple Myeloma
4
Ensartinib Reduces Recurrence Risk After Resection in ALK-Positive NSCLC
5



















